About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Phase III Trial
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Ethics Approval to Commence Topical TPM®/Oxycodone Patch Trial
December 8, 2014
Click here to read more
Post navigation
Previous Post
Phosphagenics Newsletter November 2014
Next Post
Phosphagenics Appoints Dr Ross Murdoch as Chief Executive Officer
Related Posts
2016 Annual General Meeting Results
May 19, 2016
Quarterly Activities Report and 4C – to 31 March 2023
April 28, 2023
May 20, 2023
Phosphagenics Signs Japanese License Option Agreement for TPM Oxycodone Patch
May 17, 2016